• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Auro Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4899.0
  • ISIN : INE292C01011
256.85 12 (4.79%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    250.00

  • Today’s High

    259.45

  • Open

    254.40

  • Perv Close

    245.10

  • 52W Low

    156.40

  • 52W High

    307.20

Key Indicators

  • P/E(TTM)

    45.95

  • Mar.Cap (₹Cr.)

    160.02

  • Div & Yield %

    0.00

  • Book Value(₹)

    69.61

  • Debt-Equity Ratio

    4.79

  • AGM Date

    03-Apr-2025

  • EPS

    5.59

  • P/E Ratio

    45.95

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    160.02

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.23

  • BV (₹)

    69.60

  • Sales( ₹ in Cr.)

    53.64

  • NP (in Cr.)

    7.79

  • NP Var(%)

    219.0

  • Div%

    0.0

  • CPS (₹)

    14.30

  • EPS (₹)

    12.50

  • Traded Value (₹ in Lakhs)

    160.02

  • 52 Week High

    307.20

  • 52 Week Low

    156.40

  • Price BSE

    257.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    160.02

  • P/C Ratio

    18.00

  • P/E Ratio

    20.50

  • Price Vs.BV

    12.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover - 52.89 50.87 54.25 43.79 46.82
Excise Duty - 52.26 50.44 52.93 42.90 45.56
Net Sales - 52.89 50.87 54.25 43.79 46.82
Other Income - 0.94 1.09 0.76 0.97 0.96
Stock Adjustments - 0.00 0.00 0.00 0.00 0.00
Total Income - 53.84 51.96 55.01 44.76 47.78
EXPENDITURE :
Raw Materials - 52.26 50.44 52.93 42.90 45.56
Power & Fuel Cost - 52.26 50.44 52.93 42.90 45.56
Employee Cost - 4.72 6.24 6.04 5.28 4.07
Other Manufacturing Expenses - 0.82 0.48 1.29 1.23 1.31
Selling & Administrative Expenses - 3.77 3.32 3.44 3.23 2.98
Miscellaneous Expenses - 0.82 0.48 1.29 1.23 1.31
Less : Pre-operative Expenses Capitalised :
Total Expenditure - 50.39 48.08 44.50 39.12 41.71
Operating Profit - 3.50 3.42 3.70 3.30 3.00
Interest - 0.81 0.83 0.46 0.58 0.72
Gross Profit - 3.45 3.87 10.51 5.64 6.07
Depreciation - 1.07 1.02 1.04 1.02 1.01
Profit Before Tax - 3.45 3.87 10.51 5.64 6.07
Tax - 1.00 1.07 3.20 1.52 1.62
Fringe Benefit tax - 0.00 0.00 0.00 0.00 0.00
Deferred Tax - 0.00 -0.04 0.12 0.06 0.05
Reported Net Profit - 2.44 2.84 7.18 4.05 4.40
Extraordinary Items - 3.45 3.87 10.51 5.64 6.07
Adjusted Net Profit - 2.44 2.84 7.18 4.05 4.40
Adjustment below Net Profit - 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward - 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations - 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down - 2.44 2.84 7.18 4.05 4.40
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) - 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) - 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr - 3.92 4.56 11.52 6.51 7.06
Book Value - 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr - 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    52.15%

  • Public Share Holding

    47.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,168,781 18.75 1,168,781 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,081,529 33.40 2,081,529 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,250,310 52.15 3,250,310 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 400 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 400 0.01 0 1
2] Non Institution
Bodies Corporate 106,785 1.71 94,285 27
Clearing Members 0 0.00 0 0
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 392,844 6.30 241,644 227
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 323,258 5.19 323,258 7
Individuals holding nominal share capital up to Rs. 1 lakh 1,929,680 30.96 1,381,712 8,899
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 229,213 3.68 228,713 97
Sub Total 2,981,790 47.84 2,269,622 9,258
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,232,500 100.00 5,519,932 9,265

Company Background

Auro Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Auro Laboratories Ltd
  • BSE Code : 4899.0
  • ISIN : INE292C01011

  • Incorporation Year

    1989

  • Registered Office

    K-56 MIDC Indl Area
    Tarapur Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-66635456

  • FAX

  • Chairman

    Sharat Deorah

  • Managing Director

    Sharat Deorah

  • Company Secretary

    Priyanka Gupta

  • Auditor

    Kothari Jain & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Auro Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92